Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cabazitaxel (jevtana kit) (1 trial)
aflibercept (zaltrap) (1 trial)
docetaxel (taxotere) (2 trials)
fluorouracil (efudex) (1 trial)
gemcitabine (gemzar) (2 trials)
leucovorin (1 trial)
oxaliplatin (eloxatin) (1 trial)
collagen (1 trial)
Adenocarcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 3)
Trials (5 total)
Trial APIs (8 total)